|
1
|
Rauth S, Malafa M, Ponnusamy MP and Batra
SK: Emerging trends in gastrointestinal cancer targeted therapies:
Harnessing tumor microenvironment, immune factors, and metabolomics
insights. Gastroenterology. 167:867–884. 2024.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Bray F, Laversanne M, Sung H, Ferlay J,
Siegel RL, Soerjomataram I and Jemal A: Global cancer statistics
2022: GLOBOCAN estimates of incidence and mortality worldwide for
36 cancers in 185 countries. CA Cancer J Clin. 74:229–263.
2024.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Asawa S, Nüesch M, Gvozdenovic A and Aceto
N: Circulating tumour cells in gastrointestinal cancers: Food for
thought? Br J Cancer. 128:1981–1990. 2023.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Nikkari S, McLaughlin IJ, Bi W, Dodge DE
and Relman DA: Does blood of healthy subjects contain bacterial
ribosomal DNA? J Clin Microbiol. 39:1956–1959. 2001.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Sciarra F, Franceschini E, Campolo F and
Venneri MA: The diagnostic potential of the human blood microbiome:
Are we dreaming or awake? Int J Mol Sci. 24(10422)2023.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Lee YY, An J, Han J, Moon Y and Lee SI:
Plasma-based digital PCR assay for early detection of gastric
cancer using multiple methylation biomarkers. Sci Rep.
16(1727)2025.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Law HKW and Yim HCH: Early diagnosis of
cancer using circulating microbial DNA. Cell Rep Med.
5(101502)2024.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Zhang C, Geng H, Tan Y and Wang L:
Multidimensional regulation of the microbe-TLR4 signaling axis in
colorectal cancer: From molecular mechanisms to microbe-targeted
therapies. Biochim Biophys Acta Rev Cancer.
1880(189397)2025.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Goraya MU, Li R, Mannan A, Gu L, Deng H
and Wang G: Human circulating bacteria and dysbiosis in
non-infectious diseases. Front Cell Infect Microbiol.
12(932702)2022.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Dass M, Singh Y and Ghai M: A review on
microbial species for forensic body fluid identification in healthy
and diseased humans. Curr Microbiol. 80(299)2023.PubMed/NCBI View Article : Google Scholar
|
|
11
|
De Oliveira Alves N, Dalmasso G, Nikitina
D, Vaysse A, Ruez R, Ledoux L, Pedron T, Bergsten E, Boulard O,
Autier L, et al: The colibactin-producing Escherichia coli
alters the tumor microenvironment to immunosuppressive lipid
overload facilitating colorectal cancer progression and
chemoresistance. Gut Microbes. 16(2320291)2024.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Yu J, Zhang L, Gao D, Wang J, Li Y and Sun
N: Comparison of metagenomic next-generation sequencing and blood
culture for diagnosis of bloodstream infections. Front Cell Infect
Microbiol. 14(1338861)2024.PubMed/NCBI View Article : Google Scholar
|
|
13
|
El Tekle G and Garrett WS: Bacteria in
cancer initiation, promotion and progression. Nat Rev Cancer.
23:600–618. 2023.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Chen F, Dai X, Zhou CC, Li KX, Zhang YJ,
Lou XY, Zhu YM, Sun YL, Peng BX and Cui W: Integrated analysis of
the faecal metagenome and serum metabolome reveals the role of gut
microbiome-associated metabolites in the detection of colorectal
cancer and adenoma. Gut. 71:1315–1325. 2022.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Zhou X, Kandalai S, Hossain F and Zheng Q:
Tumor microbiome metabolism: A game changer in cancer development
and therapy. Front Oncol. 12(933407)2022.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Budding AE, Grasman ME, Lin F, Bogaards
JA, Soeltan-Kaersenhout DJ, Vandenbroucke-Grauls CM, van Bodegraven
AA and Savelkoul PH: IS-pro: High-throughput molecular
fingerprinting of the intestinal microbiota. FASEB J. 24:4556–4564.
2010.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Singer M, Koedooder R, Bos MP, Poort L,
Schoenmakers S, Savelkoul PHM, Laven JSE, de Jonge JD, Morré SA and
Budding AE: The profiling of microbiota in vaginal swab samples
using 16S rRNA gene sequencing and IS-pro analysis. BMC Microbiol.
21(100)2021.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Fierer N, Leung PM, Lappan R, Eisenhofer
R, Ricci F, Holland SI, Dragone N, Blackall LL, Dong X, Dorador C,
et al: Guidelines for preventing and reporting contamination in
low-biomass microbiome studies. Nat Microbiol. 10:1570–1580.
2025.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Giacconi R, Donghia R, Arborea G, Savino
MT, Provinciali M, Lattanzio F, Caponio GR, Coletta S, Bianco A,
Notarnicola M, et al: Plasma bacterial DNA load as a potential
biomarker for the early detection of colorectal cancer: A
case-control study. Microorganisms. 11(2360)2023.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Siegel RL, Wagle NS, Cercek A, Smith RA
and Jemal A: Colorectal cancer statistics, 2023. Ca Cancer J Clin.
73:233–254. 2023.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Zhan ZS, Zheng ZS, Shi J, Chen J, Wu SY
and Zhang SY: Unraveling colorectal cancer prevention: The vitamin
D-gut flora-immune system nexus. World J Gastrointest Oncol.
16:2394–2403. 2024.PubMed/NCBI View Article : Google Scholar
|
|
22
|
López MJ, Carbajal J, Alfaro AL, Saravia
LG, Zanabria D, Araujo JM, Quispe L, Zevallos A, Buleje JL, Cho CE,
et al: Characteristics of gastric cancer around the world. Crit Rev
Oncol Hematol. 181(103841)2023.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Fakharian F, Asgari B, Nabavi-Rad A,
Sadeghi A, Soleimani N, Yadegar A and Zali MR: The interplay
between Helicobacter pylori and the gut microbiota: An
emerging driver influencing the immune system homeostasis and
gastric carcinogenesis. Front Cell Infect Microbiol.
12(953718)2022.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Hu D, Zhang F, Zhou J, Xu B, Zhang H,
Qiang H, Ren S, Shan B, Yin C, Zhang Z, et al: The clearance effect
of bovine anti-Helicobacter pylori antibody-containing milk
in O blood group Helicobacter pylori-infected patients: A
randomized double-blind clinical trial. J Transl Med.
13(205)2015.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Zhang TW, Song JC, Hao NB, Qu MY, Guo BS
and Li CZ: Continuous light-induced circadian rhythm disruption
impairs intestinal barrier integrity in male C57BL/6 mice through
gut microbiota dysbiosis and the apoptosis-inflammation-oxidative
stress cascade. bioRxiv: doi: https://doi.org/10.1101/2025.11.11.687914.
|
|
26
|
Lu J, Zhang W, He Y, Jiang M, Liu Z, Zhang
J, Zheng L, Zhou B, Luo J, He C, et al: Multi-omics decodes
host-specific and environmental microbiome interactions in sepsis.
Front Microbiol. 16(1618177)2025.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Fu Y, Kim H, Lee DS, Han A, Heine H,
Zamyatina A and Kim HM: Structural insight into TLR4/MD-2
activation by synthetic LPS mimetics with distinct binding modes.
Nat Commun. 16(4164)2025.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Li J, Qin Y, Chen Y, Zhao P, Liu X, Dong
H, Zheng W, Feng S, Mao X and Li C: Mechanisms of the
lipopolysaccharide-induced inflammatory response in alveolar
epithelial cell/macrophage co-culture. Exp Ther Med.
20(76)2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Balic JJ, Albargy H, Luu K, Kirby FJ,
Jayasekara WSN, Mansell F, Garama DJ, De Nardo D, Baschuk N, Louis
C, et al: STAT3 serine phosphorylation is required for TLR4
metabolic reprogramming and IL-1β expression. Nat Commun.
11(3816)2020.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Parsons MJ, Tammela T and Dow LE: WNT as a
driver and dependency in cancer. Cancer Discov. 11:2413–2429.
2021.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Liu L, Yan M, Yang R, Qin X, Chen L, Li L,
Si J, Li X and Ma K: Adiponectin attenuates
lipopolysaccharide-induced apoptosis by regulating the
Cx43/PI3K/AKT pathway. Front Pharmacol. 12(644225)2021.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Gao Y, Lin J, Ye C, Guo S and Jiang C:
Microbial transformations of bile acids and their receptors in the
regulation of metabolic dysfunction-associated steatotic liver
disease. Liver Res. 7:165–176. 2023.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Kong L, Hoshi N, Sui Y, Yamada Y, Yoshida
R, Ooi M, Tian Z, Kimura I and Kodama Y: GPR43 suppresses
intestinal tumor growth by modification of the mammalian target of
rapamycin complex 1 activity in ApcMin/+ mice. Med Princ Pract.
31:39–46. 2022.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Ponton-Almodovar A, Sanderson S, Rattan R,
Bernard JJ and Horibata S: Ovarian tumor microenvironment
contributes to tumor progression and chemoresistance. Cancer Drug
Resist. 7(53)2024.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Chen S, Tan Y, Xiao X, Xiao XC, Li Q, Wu
Q, Peng YY, Ren J and Dong ML: Deletion of TLR4 attenuates
lipopolysaccharide-induced acute liver injury by inhibiting
inflammation and apoptosis. Acta Pharmacol Sin. 42:1610–1619.
2021.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Netea MG, Domínguez-Andrés J, Barreiro LB,
Chavakis T, Divangahi M, Fuchs E, Joosten LAB, van der Meer JWM,
Mhlanga MM, Mulder WJM, et al: Defining trained immunity and its
role in health and disease. Nat Rev Immunol. 20:375–388.
2020.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Vinolo MAR, Rodrigues HG, Nachbar RT and
Curi R: Regulation of inflammation by short chain fatty acids.
Nutrients. 3:858–876. 2011.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Tanaka I, Ono S, Watanabe Y, Yamamoto H,
Oikawa R, Matsumoto S, Kubo M, Nishimura Y, Shimoda Y, Ono M, et
al: Long-term changes in aberrant DNA methylation and gastritis
after Helicobacter pylori eradication focused on
metachronous gastric cancer. Helicobacter.
27(e12915)2022.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Guccione C, Dantas Machado AC, Youssef F,
Angeli-Pahim I, Duarte S, Warren C, Farmer S, Humphrey G, Richter
RA, McDonald D, et al: Blood microbial DNA signature differentiates
hepatocellular carcinoma from metastatic lesions.
eGastroenterology. 3(e100193)2025.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Ramos A, Sadeghi S and Tabatabaeian H:
Battling chemoresistance in cancer: Root causes and strategies to
uproot them. Int J Mol Sci. 22(9451)2021.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Herrera-Quintana L, Vázquez-Lorente H,
Lopez-Garzon M, Cortés-Martín A and Plaza-Diaz J: Cancer and the
microbiome of the human body. Nutrients. 16(2790)2024.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Zhang H, Fu L, Leiliang X, Qu C, Wu W, Wen
R, Huang N, He Q, Cheng Q, Liu G and Cheng Y: Beyond the gut: The
intratumoral microbiome's influence on tumorigenesis and treatment
response. Cancer Commun (Lond). 44:1130–1167. 2024.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Sharma S, Hegde P, Panda S, Orimoloye MO
and Aldrich CC: Drugging the microbiome: Targeting small microbiome
molecules. Curr Opin Microbiol. 71(102234)2023.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Iida N, Dzutsev A, Stewart CA, Smith L,
Bouladoux N, Weingarten RA, Molina DA, Salcedo R, Back T, Cramer S,
et al: Commensal bacteria control cancer response to therapy by
modulating the tumor microenvironment. Science. 342:967–970.
2013.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Dong J, Li Y, Xiao H, Cui M and Fan S:
Commensal microbiota in the digestive tract: A review of its roles
in carcinogenesis and radiotherapy. Cancer Biol Med. 18:43–55.
2021.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Uribe-Herranz M, Rafail S, Beghi S,
Gil-de-Gómez L, Verginadis I, Bittinger K, Pustylnikov S, Pierini
S, Perales-Linares R, Blair IA, et al: Gut microbiota modulate
dendritic cell antigen presentation and radiotherapy-induced
antitumor immune response. J Clin Invest. 130:466–479.
2020.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Shiao SL, Kershaw KM, Limon JJ, You S,
Yoon J, Ko EY, Guarnerio J, Potdar AA, McGovern DPB, Bose S, et al:
Commensal bacteria and fungi differentially regulate tumor
responses to radiation therapy. Cancer Cell. 39:1202–1213.e6.
2021.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Colbert LE, El Alam MB, Wang R, Karpinets
T, Lo D, Lynn EJ, Harris TA, Elnaggar JH, Yoshida-Court K, Tomasic
K, et al: Tumor-resident Lactobacillus iners confer
chemoradiation resistance through lactate-induced metabolic
rewiring. Cancer Cell. 41:1945–1962.e11. 2023.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Alam MZ, Maslanka JR and Abt MC:
Immunological consequences of microbiome-based therapeutics. Front
Immunol. 13(1046472)2023.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Hizay A, Dag K, Oz N, Comak-Gocer EM,
Ozbey-Unlu O, Ucak M and Keles-Celik N: Lactobacillus
acidophilus regulates abnormal serotonin availability in
experimental ulcerative colitis. Anaerobe.
80(102710)2023.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Zheng L, Ji YY, Wen XL and Duan SL: Fecal
microbiota transplantation in the metabolic diseases: Current
status and perspectives. World J Gastroenterol. 28:2546–2560.
2022.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Davar D, Dzutsev AK, McCulloch JA,
Rodrigues RR, Chauvin JM, Morrison RM, Deblasio RN, Menna C, Ding
Q, Pagliano O, et al: Fecal microbiota transplant overcomes
resistance to anti-PD-1 therapy in melanoma patients. Science.
371:595–602. 2021.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Sun J, Song S, Liu J, Chen F, Li X and Wu
G: Gut microbiota as a new target for anticancer therapy: From
mechanism to means of regulation. NPJ Biofilms Microbiomes.
11(43)2025.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Zheng C, Chen T, Lu J, Wei K, Tian H, Liu
W, Xu T, Wang X, Wang S, Yang R, et al: Adjuvant treatment and
molecular mechanism of probiotic compounds in patients with gastric
cancer after gastrectomy. Food Funct. 12:6294–6308. 2021.PubMed/NCBI View Article : Google Scholar
|
